Literature DB >> 1563012

Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro.

H J Parry1, R C Rees.   

Abstract

Monocytes and macrophages have been shown to be cytotoxic towards tumour cells in vitro. However, although tumour-associated monocytes and macrophages are now widely accepted to contribute a relatively high proportion of the cellular infiltrate of experimental and human solid carcinomas, a cytotoxic/cytostatic effector function for these cells in vitro or in vivo has yet to be conclusively demonstrated. In the present study, we show that non-activated peripheral blood monocytes co-cultured with tumour cells across a semi-permeable membrane release soluble factors that modulate the growth of tumour cells in contrasting ways. After Nycoprep 1.068 separation, non-activated peripheral blood monocytes enhanced the in vitro proliferation of HT29 colon adenocarcinoma cells but inhibited T47D breast carcinoma cell replication; peripheral blood lymphocytes were incapable of mediating these effects. In contrast, peripheral blood monocytes activated by interferon gamma caused a pronounced inhibition of both HT29 and T47D cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563012     DOI: 10.1007/bf01741744

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  18 in total

1.  Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.

Authors:  R Feinman; D Henriksen-DeStefano; M Tsujimoto; J Vilcek
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

2.  Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  Cell Immunol       Date:  1987-09       Impact factor: 4.868

3.  Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.

Authors:  K Hori; M J Ehrke; K Mace; E Mihich
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

4.  Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes.

Authors:  T L Gerrard; J P Siegel; D R Dyer; K C Zoon
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

5.  Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.

Authors:  J E Talmadge; H R Tribble; R W Pennington; H Phillips; R H Wiltrout
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

6.  Macrophage tumor necrosis factor-alpha release is induced by contact with some tumors.

Authors:  J D Hasday; E M Shah; A P Lieberman
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

7.  Human interleukin 1 is a cytocidal factor for several tumor cell lines.

Authors:  K Onozaki; K Matsushima; B B Aggarwal; J J Oppenheim
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

8.  Role of tumor necrosis factor in macrophage activation and tumoricidal activity.

Authors:  K F Mace; M J Ehrke; K Hori; D L Maccubbin; E Mihich
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

9.  Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.

Authors:  K Hori; E Mihich; M J Ehrke
Journal:  Cancer Res       Date:  1989-05-15       Impact factor: 12.701

10.  Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion.

Authors:  S Kimura; S Sone; K Takahashi; T Uyama; T Ogura; Y Monden
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.